Meta-analyses involving cross-over trials: methodological issues

Clicks: 3
ID: 290697
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #110 of 133 articles by views in International Journal of Epidemiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 133 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Background Meta-analysis of randomized controlled trials (RCTs) is usually based on trials where patients are randomized individually into two different, parallel, treatment groups. This paper concentrates on RCTs of a different design—two-period, two-treatment cross-over trials.
Reference Key
openalex_W2130235475 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Diana R Elbourne, Douglas G. Altman, Julian P. T. Higgins, François Curtin, Helen V Worthington, Andy Vail
Journal International Journal of Epidemiology
Year 2002
DOI
10.1093/ije/31.1.140
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.